Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of Over 6,000 Patients from an International Registry

Posted on September 13, 2021 by Gastroenterology Journal
This entry was posted in News. Bookmark the permalink.